Financial Architects (New Jersey)’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
TIA
MJRIC
MCM
CCA
Financial Architects (New Jersey)'s BBH Position: Q1 2022 in Review
Financial Architects (New Jersey) sold out of VanEck Biotech ETF (BBH) in Q1 2022, closing a stake of 1,274 shares — an estimated $241K sold.
Financial Architects (New Jersey) first reported a position in BBH in Q2 2014 and held it in 28 quarters. The position peaked at $258K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.
- Financial Architects (New Jersey) reported no remaining VanEck Biotech ETF position as of Q1 2022 after selling out during the quarter.
- Financial Architects (New Jersey) sold 1,274 VanEck Biotech ETF shares in Q1 2022, an estimated $241K.
- Financial Architects (New Jersey) first reported a position in VanEck Biotech ETF in Q2 2014 and held it in 28 quarters.
- Financial Architects (New Jersey)'s VanEck Biotech ETF position peaked at $258K in Q3 2021.
- 115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.
Based on Financial Architects (New Jersey)'s 13F filing for Q1 2022, filed 5 May 2022.